Intracranial Embolism and Thrombosis: Clinical Trials

82 trials for Intracranial Embolism and Thrombosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 14 recruiting, 14 unknown, 5 active not recruiting. 19 Not applicable, 15 Phase 3, 6 Phase 2, 3 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 12, Unknown 3, Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1
Phase 315Completed 6, Unknown 5, Recruiting 2, Terminated 2
Phase 26Terminated 3, Completed 2, Unknown 1
Phase 43Completed 1, Recruiting 1, Unknown 1
Phase 12Completed 1, Unknown 1

Follow Intracranial Embolism and Thrombosis: new trials by email Literature Review of Intracranial Embolism and Thrombosis trials Research Report on Intracranial Embolism and Thrombosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus Thrombosis
Cerebral Thrombosis, Venous Thrombosis
Not yet recruitingAssiut University802026-10-202026-10-22
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
18F/68Ga-GP1 - Thrombi, Thrombus, Brain
RecruitingTianjin Medical University5002026-09-012026-09-10
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
Carotid Artery Disease, Symptomatic Carotid Artery Stenosis
RecruitingAcandis GmbH5362026-03-012026-03-04
Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
batroxobin, Anticoagulation Agents - Cerebral Venous Thrombosis
Phase 4RecruitingXuanwu Hospital, Beijing722026-01-302026-01-20
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
Tenecteplase, Alteplase - Stroke, Ischemic, Stroke, Acute
Phase 3RecruitingXuanwu Hospital, Beijing8502025-12-252026-04-09
Danang Cerebral Venous Thrombosis Registry
Standard Anticoagulant Therapy - Cerebral Venous Sinus Thrombosis, Stroke
RecruitingDa Nang Hospital1102025-10-092026-10-26
Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
Dabigatran, Rivaroxaban - Cerebral Venous Thrombosis
RecruitingHieu Trung Dinh692025-07-112026-10-09
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Cerebral Venous Thrombosis, Anticoagulants and Thrombotic Disorders
RecruitingXuanwu Hospital, Beijing14862025-04-102025-04-27
Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis
Tocilizumab, Standard Treatment - Cerebral Venous Thrombosis
Not applicableRecruitingCapital Medical University802025-03-012026-09-09
Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
Dabigatran Etexilate 150mg, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Sinus Thrombosis
Phase 3RecruitingKafrelsheikh University2002024-08-092024-08-13
REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
Intra Cerebral Hemorrhage, ICH - Intracerebral Hemorrhage
Active not recruitingJohns Hopkins University3502023-05-232026-06-12
Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study
Cerebral Venous Thrombosis
CompletedBeijing Tiantan Hospital2732023-01-012024-02-20
Thrombus Imaging and Treatment Analytics in Neurology
thrombus imaging appearance - Thrombus, Brain, Thrombosis
RecruitingChinese PLA General Hospital1002022-12-152024-07-03
Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
CompletedCapital Medical University32762022-08-202024-02-26
Florida Cerebrovascular Disease Biorepository and Genomics Center
Cerebrovascular Disease, Ischemic Stroke
Active not recruitingMayo Clinic722022-08-022026-09-03
Anatomical Variation of Cerebral Venous Sinus in Healthy Individuals
anotomy and variation of venous sinus, the level of biomarker in bood - Venous Sinus Thrombosis, Cranial
UnknownCapital Medical University402022-07-062023-04-18
Venous Sinus Thrombosis : Clinical Picture and Outcome
Cerebral Vein Thrombosis
UnknownAssiut University502022-05-012022-01-27
Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
Dabigatran Etexilate 150mg, Apixaban 5MG - Cerebral Venous Sinus Thrombosis
Phase 3UnknownKafrelsheikh University2002021-08-012024-08-13
Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Apixaban 5MG, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Thrombosis
Phase 3UnknownKafrelsheikh University2002021-08-012024-08-19
Philippine Neurological Association One Database - Stroke
Transient Ischemic Attack, Ischemic Stroke
CompletedPhilippine Neurological Association148002021-06-012024-11-12

Showing 20 of 82. Sign in to see all of them.

Narrower conditions

Intracranial Thrombosis (46)  ·  Intracranial Embolism (21)  ·  Stroke (21)  ·  Thrombosis (13)  ·  Ischemic Stroke (9)  ·  Cerebral Hemorrhage (7)  ·  Subarachnoid Hemorrhage (7)  ·  Venous Thrombosis (7)  ·  Carotid Stenosis (6)  ·  Cerebrovascular Disorders (5)  ·  Aortic Valve Stenosis (4)  ·  Atrial Fibrillation (4)  ·  Ischemic Attack, Transient (4)  ·  Pulmonary Embolism (4)

Broader conditions

Brain Diseases (82)  ·  Central Nervous System Diseases (82)  ·  Embolism and Thrombosis (82)  ·  Thromboembolism (82)  ·  Nervous System Diseases (81)  ·  Vascular Diseases (81)  ·  Cardiovascular Diseases (80)  ·  Cerebrovascular Disorders (77)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Pathologic Processes (22)  ·  Heart Diseases (11)  ·  Arterial Occlusive Diseases (9)  ·  Brain Ischemia (9)  ·  Intracranial Hemorrhages (9)

Interventions

Rivaroxaban (7)  ·  Warfarin (6)  ·  Dabigatran (5)  ·  apixaban (5)  ·  Tissue Plasminogen Activator (3)  ·  Anticoagulants (2)  ·  Dalteparin (2)  ·  Endarterectomy, Carotid (2)  ·  Heparin (2)  ·  Tenecteplase (2)  ·  Ultrasonography, Doppler, Transcranial (2)  ·  ARC 1779 (1)  ·  Argininosuccinate Synthase (1)  ·  Batroxobin (1)  ·  Blood Specimen Collection (1)

Sponsors

Insel Gruppe AG, University Hospital Bern (5)  ·  Capital Medical University (4)  ·  Xuanwu Hospital, Beijing (4)  ·  Kafrelsheikh University (3)  ·  Academic and Community Cancer Research United (2)  ·  Assiut University (2)  ·  Charite University, Berlin, Germany (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Acandis GmbH (1)  ·  Annette Schophuus Jensen (1)  ·  AorticLab Srl (1)  ·  Archemix Corp. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Auckland City Hospital (1)  ·  Augusta University (1)

Countries

China (13)  ·  United States (13)  ·  Canada (8)  ·  France (8)  ·  Switzerland (8)  ·  Germany (7)  ·  Netherlands (6)  ·  Egypt (3)  ·  Israel (3)  ·  Italy (3)  ·  Portugal (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Denmark (2)  ·  Japan (2)

Top investigators

Gabor Erdoes, MD (2)  ·  Thierry Carrel, MD, PhD (2)  ·  Adrian Covic, Professor (1)  ·  Akihiko Taguchi, MD.PhD (1)  ·  Annette S Jensen, MD, PhD (1)  ·  Asad Ikram, MD (1)  ·  Atif Zafar, MD (1)  ·  Audrey Arnoux, MD (1)  ·  Bijoy K Menon, MD (1)  ·  Carina M Blomstrom Lundqvist, MD, PhD (1)  ·  Charles BL Majoie, MD, PhD (1)  ·  David J. Malenka, MD (1)  ·  Donald Brambilla (1)  ·  Donald S Likosky, Ph.D. (1)

Results publications

PMID 18190818, PMID 31867054, PMID 15376771, PMID 15559738, PMID 15769702, PMID 16283980, PMID 19721013, PMID 20031837, PMID 20437790, PMID 21600512, PMID 21700934, PMID 22340437, PMID 25967578, PMID 28837207, PMID 29562937, PMID 29792215, PMID 30898234, PMID 30957581, PMID 31606897, PMID 31630479, PMID 32208831, PMID 32421159, PMID 32576633, PMID 32797064, PMID 32883194, PMID 33028663, PMID 34006504, PMID 34753444, PMID 34819911, PMID 35613760, PMID 35733810, PMID 35777693, PMID 35779553, PMID 37086083, PMID 37675613, PMID 37780701, PMID 37800372, PMID 38174568, PMID 38275116, PMID 38537780, PMID 38541922, PMID 38622893, PMID 38876748, PMID 38939654, PMID 39373400, PMID 39379314, PMID 39460849, PMID 39815140, PMID 39915023, PMID 39986309

NIH funding

2018 (1), P30CA015083 (1), R01HL033233 (1), R01HL072946 (1), R01NS120557 (1), U01HL052193 (1)